P2Y12 antagonists and cardiac repair post-myocardial infarction: global and regional heart function analysis and molecular assessments in pigs
Author(s) -
Gemma Vilahur,
Manuel Gutiérrez,
Laura Casaní,
Carmen Lambert,
Guiomar Mendieta,
Soumaya BenAicha,
Antoni Capdevila,
Guillem PonsLladó,
Francesc Carreras,
Leif Carlsson,
Alberto Hidalgo,
Lina Badimón
Publication year - 2018
Publication title -
cardiovascular research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.774
H-Index - 219
eISSN - 1755-3245
pISSN - 0008-6363
DOI - 10.1093/cvr/cvy201
Subject(s) - ticagrelor , clopidogrel , medicine , cardiology , myocardial infarction , p2y12 , ejection fraction , aspirin , anesthesia , heart failure
P2Y12 antagonists are the standard in antiplatelet therapy but their potential effects on functional myocardial recovery and cardioprotection post-myocardial infarction (MI) are unknown. We investigated in a preclinical model of MI whether ticagrelor and clopidogrel differently affect cardiac repair post-MI.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom